Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program

Gastroenterology

Volumn 147, Issue 3, 2014, Pages

  Auge, Josep M ^a   Pellise, Maria ^b   Escudero, José M ^a   Hernandez, Cristina ^c   Andreu, Montserrat ^c   Grau, Jaume ^b   Buron, Andrea ^c   López Cerón, María ^b   Bessa, Xavier ^c   Serradesanferm, Anna ^b   Piracés, Mercè ^c   Macià, Francesc ^c   Guayta, Rafael ^d   Filella, Xavier ^a   Molina, Rafael ^a   Jimenez, Wladimiro ^a   Castells, Antoni ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d Projects and Research Directorate   (Spain)

Author keywords

Colonoscopy; Colorectal Cancer Screening; Fecal Immunochemical Tests; Risk Stratification

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CLINICAL EXAMINATION; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL TUMOR; FECAL HEMOGLOBIN CONCENTRATION; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

COLONOSCOPY; COLORECTAL CANCER SCREENING; FECAL IMMUNOCHEMICAL TESTS; RISK STRATIFICATION;

AGE FACTORS; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOCHEMISTRY; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; OCCULT BLOOD; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SPAIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84906936922     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.06.008     Document Type: Article

References (52)

1. A. Jemal, F. Bray, and M.M. Center et al. Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. D. Cunningham, W. Atkin, and H.J. Lenz et al. Colorectal cancer Lancet 375 2010 1030 1047
3. K. Soreide, B.S. Nedrebo, and J.C. Knapp et al. Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist Surg Oncol 18 2009 31 50
4. J.D. Hardcastle, W.M. Thomas, and J. Chamberlain et al. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects Lancet 1 1989 1160 1164 (Pubitemid 19138850)
5. O.D. Jorgensen, O. Kronborg, and C. Fenger A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds Gut 50 2002 29 32 (Pubitemid 34028299)
6. J.S. Mandel, T.R. Church, and F. Ederer et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood J Natl Cancer Inst 91 1999 434 437 (Pubitemid 29128279)
7. L. Guittet, V. Bouvier, and N. Mariotte et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population Gut 56 2007 210 214
8. L. Hol, J.A. Wilschut, and M. van Ballegooijen et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels Br J Cancer 100 2009 1103 1110
9. L. Hol, V. de Jonge, and M.E. van Leerdam et al. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy Eur J Cancer 46 2010 2059 2066
10. D.I. Park, S. Ryu, and Y.H. Kim et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening Am J Gastroenterol 105 2010 2017 2025
11. T. Raginel, J. Puvinel, and O. Ferrand et al. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening Gastroenterology 144 2013 918 925
12. L.G. van Rossum, A.F. van Rijn, and R.J. Laheij et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population Gastroenterology 135 2008 82 90 (Pubitemid 351899018)
13. E.P. Whitlock, J.S. Lin, and E. Liles et al. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force Ann Intern Med 149 2008 638 658
14. L.G. van Rossum, A.F. van Rijn, and R.J. Laheij et al. Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme Br J Cancer 101 2009 1274 1281
15. J.M. Canard, M. Debette-Gratien, and R. Dumas et al. A prospective national study on colonoscopy and sigmoidoscopy in 2000 in France Gastroenterol Clin Biol 29 2005 17 22 (Pubitemid 40254644)
16. P. Tappenden, J. Chilcott, and S. Eggington et al. Option appraisal of population-based colorectal cancer screening programmes in England Gut 56 2007 677 684 (Pubitemid 46662935)
17. J.S. Terhaar sive Droste, M.E. Craanen, and J.J. Kolkman et al. Dutch endoscopic capacity in the era of colorectal cancer screening Neth J Med 64 2006 371 373 (Pubitemid 44811214)
18. P. Kanavos, and W. Schurer The dynamics of colorectal cancer management in 17 countries Eur J Health Econ 10 Suppl 1 2010 S115 S129
19. A. Castells, S. Castellvi-Bel, and F. Balaguer Concepts in familial colorectal cancer: where do we stand and what is the future? Gastroenterology 137 2009 404 409
20. Hospital Clinic, Parc de Salut Mar, Col.legi de Farmaceutics de Barcelona. Programa de detecció precoç de càncer de còlon i recte: Barcelona Esquerra-Litoral Mar. Pla Funcional. Barcelona: 2010.
21. V. Pinol, A. Castells, and M. Andreu et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer JAMA 293 2005 1986 1994 (Pubitemid 40570892)
22. B. Levin, D.A. Lieberman, and B. McFarland et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology 134 2008 1570 1595 (Pubitemid 351615355)
23. N. Segnan, J. Patnick, and L. von Karsa European guidelines for quality assurance in colorectal cancer screening and diagnosis 2010 Publications Office of the European Union Luxembourg
24. C. Hassan, E. Quintero, and J.M. Dumonceau et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline Endoscopy 45 2013 842 851
25. L.H. Sobin, M. Gospodarowicz, and C. Wittekind TNM classification of malignant tumours 7th ed. 2009 Wiley-Blackwell New York
26. C.G. Fraser, J.E. Allison, and G.P. Young et al. A standard for Faecal Immunochemical TesTs for Haemoglobin Evaluation Reporting (FITTER) Ann Clin Biochem 51 2014 301 302
27. C.G. Fraser, J.E. Allison, and S.P. Halloran et al. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin J Natl Cancer Inst 104 2012 810 814
28. Z. Levi, P. Rozen, and R. Hazazi et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia Ann Intern Med 146 2007 244 255 (Pubitemid 351650610)
29. A. Vilkin, P. Rozen, and Z. Levi et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test Am J Gastroenterol 100 2005 2519 2525
30. D.W. Hosmer, and S. Lemeshow A goodness-of-fit test for the multiple logistic regression model Commun Stat A10 1980 1043 1069
31. C.G. Fraser, J.E. Allison, and G.P. Young et al. Quantitation of hemoglobin improves fecal immunochemical tests for noninvasive screening Clin Gastroenterol Hepatol 11 2013 839 840
32. S. Ciatto, F. Martinelli, and G. Castiglione et al. Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme Br J Cancer 96 2007 218 221 (Pubitemid 46160624)
33. J. Digby, C.G. Fraser, and F.A. Carey et al. Faecal haemoglobin concentration is related to severity of colorectal neoplasia J Clin Pathol 66 2013 415 419
34. J.B. Edwards Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value Pathology 37 2005 565 568 (Pubitemid 43030883)
35. C.G. Fraser, C.M. Mathew, and K. McKay et al. Automated immunochemical quantitation of haemoglobin in faeces collected on cards for screening for colorectal cancer Gut 57 2008 1256 1260
36. G. Grazzini, C.B. Visioli, and M. Zorzi et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer 100 2009 259 265
37. C.S. Liao, Y.M. Lin, and H.C. Chang et al. Application of quantitative estimates of fecal hemoglobin concentration for risk prediction of colorectal neoplasia World J Gastroenterol 19 2013 8366 8372
38. P. Rozen, D. Comaneshter, and Z. Levi et al. Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use Cancer 116 2010 2115 2125
39. J.A. Wilschut, J.D. Habbema, and M.E. van Leerdam et al. Fecal occult blood testing when colonoscopy capacity is limited J Natl Cancer Inst 103 2011 1741 1751
40. G. Castiglione, G. Grazzini, and G. Miccinesi et al. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood J Med Screen 9 2002 99 103 (Pubitemid 35205230)
41. S. Hamza, V. Dancourt, and C. Lejeune et al. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer Eur J Cancer 49 2013 2727 2733
42. I. Stegeman, T.R. de Wijkerslooth, and E.M. Stoop et al. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy Gut 63 2014 466 471
43. F.A. Haggar, and R.P. Boushey Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors Clin Colon Rectal Surg 22 2009 191 197
44. P.J. McDonald, J.A. Strachan, and J. Digby et al. Faecal haemoglobin concentrations by gender and age: implications for population-based screening for colorectal cancer Clin Chem Lab Med 50 2012 935 940
45. F.T. Kolligs, A. Crispin, and A. Munte et al. Risk of advanced colorectal neoplasia according to age and gender PLoS One 6 2011 e20076
46. E. Quintero, A. Castells, and L. Bujanda et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening N Engl J Med 366 2012 697 706
47. J.A. Hanley Analysis of mortality data from cancer screening studies: looking in the right window Epidemiology 16 2005 786 790 (Pubitemid 41681546)
48. J.A. Driver, J.M. Gaziano, and R.P. Gelber et al. Development of a risk score for colorectal cancer in men Am J Med 120 2007 257 263 (Pubitemid 46341164)
49. A.N. Freedman, M.L. Slattery, and R. Ballard-Barbash et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility J Clin Oncol 27 2009 686 693
50. F. Omata, A. Shintani, and M. Isozaki et al. Diagnostic performance of quantitative fecal immunochemical test and multivariate prediction model for colorectal neoplasms in asymptomatic individuals Eur J Gastroenterol Hepatol 23 2011 1036 1041
51. L.S. Chen, A.M. Yen, and C.G. Fraser et al. Impact of faecal haemoglobin concentration on colorectal cancer mortality and all-cause death BMJ Open 3 2013 e003740
52. A. Castells, X. Bessa, and E. Quintero et al. Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies J Natl Cancer Inst 105 2013 878 886 i de Recerca